Fused heterocyclic compounds

Details Fused heterocyclic compounds Fused heterocyclic compounds

2007-12-28

2011-10-18

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S394000, C548S307400

Reexamination Certificate

active

08039500

ABSTRACT:
There is provided a compound of the formula:wherein R1is an optionally substituted hydrocarbyl, a substituted amino, etc.; R2is an aromatic group substituted with one or two substituents at the positions adjacent to the position bonded to Z, and said aromatic group may have additional substituent(s); X is —NR3— wherein R3is a hydrogen, an optionally substituted hydrocarbyl or an acyl, or sulfur; Y1, Y2and Y3are an optionally substituted methine or a nitrogen, etc.; and Z is an optionally substituted methylene, provided that carbonyl is excluded; or a salt thereof or a prodrug thereof, which have CRF receptor antagonist activity and use thereof.

REFERENCES:
patent: 2006/0160872 (2006-07-01), Norman et al.
patent: 0 178 413 (1986-04-01), None
patent: 96/11917 (1996-04-01), None
patent: 97/48697 (1997-12-01), None
patent: 98/05327 (1998-02-01), None
patent: 98/38188 (1998-09-01), None
patent: 03/037860 (2003-05-01), None
patent: 2005/044793 (2005-05-01), None
patent: 2005/060958 (2005-07-01), None
patent: 2005/099688 (2005-10-01), None
patent: 2006/062972 (2006-06-01), None
patent: 2006/099379 (2006-09-01), None
patent: 2006/116412 (2006-11-01), None
patent: 2007/017794 (2007-02-01), None
patent: 2008/051533 (2008-05-01), None
STN—12448271—09282010.
Deng et al., Bioorg. Med. Chem. Lett., vol. 15, (2005), p. 4411-16.
International Search Report issued Jun. 12, 2008 in International (PCT) Application No. PCT/JP2007/075427.
D. J. Sall et al., “Inhibition of Phenylethanolamine N-Methyltransferase (PNMT) by Aromatic Hydroxy-Substituted 1,2,3,4-Tetrahydroisoquinolines: Further Studies on the Hydrophilic Pocket of the Aromatic Ring Binding Region of the Active Site”, J. Med. Chem., vol. 30, pp. 2208-2216, 1987.
D. Sperandio et al., “Highly Potent Non-Peptide Inhibitors of the HCV NS3/NS4A Serine Protease”, Bioorganic & Medicinal Chemistry Letters, vol. 12, pp. 3129-3133, 2002.
S. P. Gupta et al., “Quantitative Structure-Activity Relationship Study on Some 5-Lipoxygenase Inhibitors”, J. Enzyme Inhibition, vol. 3, pp. 179-188, 1990.
R. Chen et al., “Expression cloning of a human corticotropin-releasing-factor receptor”, Proc. Natl. Acad. Sci., vol. 90, pp. 8967-8971, Oct. 1993.

Affiliated with

Also associated with

Rating

Fused heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused heterocyclic compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4285291